The largest Diagnostics Company in India, SRL partners with Microsoft to bolster their AI network for Healthcare to pathology. The company will be using Microsoft Azure and AI innovations to improve the quality of digital pathology. With the collaboration, Microsoft for the first time providing AI solutions for pathology.
Microsoft is committed to empower both the healthcare industry and patients by using AI to democratize healthcare for all. Our partnership with SRL Diagnostics will assist pathologists by equipping them with technology that will augment their capability. This is the third area where we have expanded our AI Network for Healthcare after eyecare and cardiology. We will continue to look for other areas where we can deploy technology to make healthcare more accessible. – Anil Bhansali, Managing Director, Microsoft India
SLR Diagnostics being the top player, has more than a million histopathology(the study of changes in tissues) slides which would be used for training an AI algorithm. Besides pathology, the Redmond giant also launched Cardiovascular Disease Risk Score API for the Indian population.
In line with SRL’s vision to help people on their path to better health, we are delighted to be partnering with Microsoft to co-create solutions and generate both social and business value. Diagnosis is the first step to disease management, as without accurate identification of the cause there is no possibility of a precise treatment. With the growing number of samples of cancer, as well as of other diseases, there’s a need to quickly and accurately analyze the samples to help doctors arrive at a diagnosis faster. The AI platform that Microsoft will build in collaboration with SRL is expected to create a software environment infused with millions of data points and knowledge gained from SRL’s expert laboratory professionals.”“In line with SRL’s vision to help people on their path to better health, we are delighted to be partnering with Microsoft to co-create solutions and generate both social and business value. Diagnosis is the first step to disease management, as without accurate identification of the cause there is no possibility of a precise treatment. With the growing number of samples of cancer, as well as of other diseases, there’s a need to quickly and accurately analyze the samples to help doctors arrive at a diagnosis faster. The AI platform that Microsoft will build in collaboration with SRL is expected to create a software environment infused with millions of data points and knowledge gained from SRL’s expert laboratory professionals. – Arindam Haldar, CEO, SRL Diagnostics
